Latest Breaking News On - From mogrifyoct - Page 1 : comparemela.com

Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing.

United-kingdom
Tadayoshi-hirata
Jonathan-milner
Darrinm-disley
Mogrify-limited
Abcam-plc
Astellas-pharma-inc
Trend-investment-group
From-mogrifyoct
Astellas-venture-management
Parkwalk-advisors
Ahren-innovation-capital